Skip to content
healthcare.dev

gadobutrol

NDC 70436-213, gadobutrol, injection, from Slate Run Pharmaceuticals, LLC.

Product NDC
70436-213
Status
Listed
Labeler
Slate Run Pharmaceuticals, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217480
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70436-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GADOBUTROL604.72 mg/mL

Pharmacologic classes

Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]

Package NDCNDC-11Package
70436-213-827043602138210 VIAL, SINGLE-DOSE in 1 CARTON (70436-213-82) / 10 mL in 1 VIAL, SINGLE-DOSE (70436-213-33)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/832e0ae1-4fe1-4dff-9978-c9200bcebb55
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70436-213

Use it

Look up 70436-213 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70436-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70436-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.